Expert Opinion on Therapeutic Targets

Chemical genetic analysis of signal transduction pathways
pp. 485-488(4)
Authors: Jaeschke, Anja; Davis, Roger J

Fatalities in natalizumab treatment - a `no go' for leukocyte recirculation approaches?
pp. 489-499(11)
Authors: Li, Yi-Yang Yvonne; Perez, H Daniel; Zollner, Thomas M

Inhibiting angiogenesis: interview with Dr Jean Plouët
pp. 501-503(3)
Author: Quigley, Emma

Targeting protein aggregation in neurodegeneration - lessons from polyglutamine disorders
pp. 505-513(9)
Authors: Weydt, Patrick; La Spada, Albert R

Targeting the dopamine D₂ receptor in schizophrenia
pp. 515-531(17)
Author: Seeman, Philip

Targeting invading macrophage- derived PGE₂, IL-6 and calcitonin gene-related peptide in injured nerve to treat neuropathic pain
pp. 533-546(14)
Authors: Ma, Weiya; Quirion, Rémi

Pharmacological targets in the treatment of abdominal aortic aneurysms
pp. 547-559(13)
Authors: Bergoeing, Michel P; Thompson, Robert W; Curci, John A

High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular disease
pp. 561-572(12)
Authors: Gomaraschi, Monica; Calabresi, Laura; Franceschini, Guido

Targeting adiponectin for cardioprotection
pp. 573-581(9)
Authors: Ouchi, Noriyuki; Shibata, Rei; Walsh, Kenneth

The role of hypoxia inducible factor-1 in cell metabolism - a possible target in cancer therapy
pp. 583-599(17)
Authors: Bel Aiba, Rachida S; Dimova, Elitsa Y; Görlach, Agnes; Kietzmann, Thomas

Possible drug targets for celiac disease
pp. 601-611(11)
Authors: Gianfrani, Carmen; Auricchio, Salvatore; Troncone, Riccardo

Alternative isoform discrimination by the next generation of expression profiling microarrays
pp. 613-625(13)
Authors: Pando, Matthew P; Kotraiah, Vinayaka; McGowan, Kevin; Bracco, Laurent; Einstein, Richard

Phosphoinositide 3-kinase-γ as a target in rheumatoid arthritis and systemic lupus
pp. 627-630(4)
Author: Doggrell, Sheila A